The statistical analysis of graft patency data in a clinical trial of antiplatelet agents following coronary artery bypass grafting
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 9 (3), 189-205
- https://doi.org/10.1016/0197-2456(88)90060-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.Circulation, 1988
- Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.Circulation, 1985
- Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.Heart, 1985
- IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)The Lancet, 1984
- Effect of Ticlopidine on Saphenous Vein Bypass Patency Rates: A Double-blind StudyThe Annals of Thoracic Surgery, 1984
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Effects of sulfinpyrazone on early graft closure after myocardial revascularizationThe American Journal of Cardiology, 1982
- Influence of Aspirin and Dipyridamole on Patency of Coronary Artery Bypass GraftsThe Annals of Thoracic Surgery, 1981
- Failure of Antiplatelet and Anticoagulant Therapy to Improve Patency of Grafts after Coronary-Artery BypassNew England Journal of Medicine, 1979